InfuSystem Beats Q3 Profit Estimates on Oncology, Wound Care Growth
InfuSystem reported Q3 profit above estimates, citing growth in oncology and wound care.
Related stories
Lincoln International Reports Q3 2026 Financial Results
Lincoln International reported third-quarter and year-to-date revenues of $293.7 million and $677.1 million, respectively.
M impact | EQUITY | Nov 05, 2026, 12:15 PM UTC
Appian Announces Third-Quarter 2026 Financial Results
M impact | EQUITY | Nov 05, 2026, 12:06 PM UTC
REGENXBIO Reports Third-Quarter 2026 Results
REGENXBIO reported third-quarter 2026 financial results and operational highlights. Its RGX-202 BLA submission for Duchenne muscular dystrophy is on track for Q1 2027, with potenti
M impact | EQUITY | Nov 05, 2026, 12:05 PM UTC
Unity Expects Q4 Revenue of $683M–$691M
M impact | EQUITY | Nov 05, 2026, 12:05 PM UTC
N-able Reports Third-Quarter Total ARR of $553.1 Million
M impact | EQUITY | Nov 05, 2026, 12:05 PM UTC
Bob's Discount Furniture Q3 earnings snapshot
M impact | EQUITY | Nov 05, 2026, 12:05 PM UTC